Entering text into the input field will update the search result below

Seagen Inc. (SGEN) CEO Clay Siegall on Q1 2021 Results - Earnings Call Transcript

May 01, 2021 8:29 AM ETSeagen Inc. (SGEN) Stock
SA Transcripts profile picture
SA Transcripts

Seagen Inc. (NASDAQ:SGEN) Q1 2021 Earnings Conference Call April 29, 2021 4:30 PM ET

Company Participants

Peggy Pinkston - Senior Vice President of Investor Relations

Clay Siegall - President and Chief Executive Officer

Chip Romp - Executive Vice President, Commercial U.S

Todd Simpson - Chief Financial Officer

Roger Dansey - Chief Medical Officer

Conference Call Participants

Greg Harrison - Bank of America

Connor Meehan - Morgan Stanley

Salveen Richter - Goldman Sachs

Turner Kufe - JPMorgan

Michael Schmidt - Guggenheim

Andrew Berens - SVB Leerink

Kennen MacKay - RBC Capital Markets

Xiaozhou Fan - Barclays

Ellen Sands - Stifel

Andy Hsieh - William Blair

Jay Olson - Oppenheimer

Ren Benjamin - JMP Securities

Shanshan Xu - Berenberg

Brad Canino - Credit Suisse


Good day and welcome to Seagen's First Quarter 2021 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Peggy Pinkston, Senior Vice President of Investor Relations. Please go ahead.

Peggy Pinkston

Thank you, operator, and good afternoon, everyone. I'd like to welcome all of you to Seagen's First Quarter 2021 Financial Results Conference Call. This afternoon, we issued a press release with our results. The press release and supporting slides are available on our website in the Investors section, Events and Presentations page.

Speakers on today's call will be Clay Siegall, President and Chief Executive Officer; Chip Romp, Executive Vice President, Commercial U.S.; Todd Simpson, Chief Financial Officer; and Roger Dansey, Chief Medical Officer. Following our prepared remarks, we'll open the line for questions. We aim to keep this call to 1 hour. [Operator Instructions]

Today's conference call will include forward-looking statements regarding future or anticipated events and results, including the company's 2021 financial outlook; anticipated product sales, revenues, costs and expenses; and potential clinical and regulatory milestones, including

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About SGEN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SGEN

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.